This proposal on Alzheimer's disease submitted to the Two Sessions hits the nerve of 10 million families
When we talk about Alzheimer's disease (AD), we are not referring to cold research data in a laboratory or rigid assessment scales in a hospital. Rather, it represents an indescribably heavy burden borne by millions of families-it is the gas stove an elderly person forgets to turn off in the middle of the night, the missing person flyers posted on the streets at 3 a.m., and the tears caregivers swallow during countless sleepless nights of despair. For China's more than 15 million people living with cognitive impairment, AD has long transcended the realm of medical terminology to become a daily ordeal and challenge for families. Breaking the cycle where the disease is often diagnosed at a moderate-to-severe stage has become a pressing health challenge that society must address.
At the 2026 National People's Congress and Chinese People's Political Consultative Conference, Zhou Yunjie, a National People's Congress deputy and Chairman of the Board of Directors of Haier Group, submitted a proposal titled "On Building a Specialized Service Ecosystem for Alzheimer's Disease," charting a course for this critical battle. This proposal breaks away from the traditional mindset of "prioritizing treatment over prevention" and focuses on the full life cycle of "prevention-screening-diagnosis-care." It accurately identifies the core pain point in current prevention and treatment efforts: the missed window for early intervention. The proposal explicitly recommends moving screening efforts forward, establishing a collaborative closed-loop system among "families-communities-hospitals," and ensuring that early screening, early diagnosis, and early intervention take root.
The actual data is alarming: currently, less than 30% of Alzheimer's disease (AD) patients in China seek medical care, and among those who are diagnosed, over 70% are already in the moderate-to-severe stage at their first visit. The mild cognitive impairment (MCI) stage-which should be the golden window for intervention-is often easily overlooked. Delving into the underlying causes reveals both societal misconceptions-where family members commonly equate "senile confusion" with normal aging-and the limitations of traditional screening models: In the traditional medical context, cognitive screening involves rigid tests like "drawing a clock" or "recalling words," and requires visiting a psychiatric or neurology clinic. This approach deeply wounds the pride of China's elderly; no one is willing to admit that their "brain is failing." An invisible barrier of "stigma" prevents countless people from seizing the optimal window for intervention.
How can we break through this barrier and make early screening and intervention both acceptable and feasible? HSAP wields technology as its tool, independently developing the "ADDS Screening + ADTS Training" closed-loop management model. By using innovative technology to redefine the path for Alzheimer's disease prevention and treatment, it eliminates the awkwardness of screening and infuses intervention with warmth, perfectly aligning with the core call in the Two Sessions proposals to "build a full-lifecycle service ecosystem."
During the screening phase, the ADDS cognitive impairment screening completely overcomes the limitations of traditional scales by replacing "manual evaluation" with "human-computer interaction," making the screening process effortless and stress-free. The system leverages neurofeedback technology, combining questionnaire responses with EEG monitoring, and uses specialized AI algorithms to intelligently analyze the risk of cognitive impairment. Examinees need not face probing questions from doctors; they simply complete a simple interaction with the computer to finish the entire screening process. Upon completion, the device intelligently generates precise diagnostic results.
This contactless, stress-free screening method not only significantly enhances the objectivity and accuracy of testing but also fundamentally alleviates the stigma associated with illness among the elderly, making proactive screening possible and truly achieving the prevention and treatment goal of "early detection." This is also the core advantage of technology companies in using innovative technologies to address industry pain points through a "dimension-reduction" approach. As a key component of HSAP's end-to-end health management product suite, the ADDS system works in tandem with other mind-body health monitoring devices to establish a comprehensive framework for full-cycle, all-around early screening, laying a solid foundation for closed-loop management.
If ADDS screening is the key to "early detection," then ADTS memory impairment training is the core of "early intervention." For individuals with mild cognitive impairment, HSAP innovatively applies non-invasive brain-computer interface technology to transform tedious rehabilitation training into engaging "mind-controlled games"-patients do not need to take medication; simply by mentally controlling the game's progression, they can enhance cognitive abilities such as attention and memory in a relaxed and enjoyable interactive environment. Based on dynamic EEG and behavioral control technology, this ADTS training system uses specialized intelligent rehabilitation games to activate neurons in the cerebral cortex and halt the further decline of memory and brain function. Its user-friendly design not only increases patient engagement but also ensures the sustainability of long-term intervention, truly achieving the goal of "early intervention and slowing progression." It is suitable for a variety of settings, including homes, geriatric hospitals, and nursing homes.
Neurological conditions such as Alzheimer's disease, stroke, and depression have long been major global health challenges. Their prevention and treatment have never been the result of isolated efforts but rather require comprehensive coordination spanning screening, home-based prevention, community services, and hospital interventions. As a high-tech enterprise dedicated to the research and development of health management devices for the entire life cycle, HSAP has consistently centered its efforts on artificial intelligence technology, deeply engaging in the field of Alzheimer's disease prevention and treatment. Its "ADDS Screening + ADTS Training" closed-loop management model not only bridges the critical link between "screening and intervention" but also aligns with the proposal by Representative Zhou Yunjie to "build a collaborative closed-loop among home, community, and medical care." This model creates a complete closed-loop encompassing "prevention, screening, diagnosis, and intervention," providing patients with end-to-end, personalized solutions.
From intelligent screening that breaks the stigma of the disease to engaging mind-controlled training; from accurately identifying early-stage risks to scientifically slowing disease progression, HSAP leverages technological innovation to address the pain points and challenges in Alzheimer's prevention and treatment, turning "early detection and early intervention" from a slogan into reality. In the future, HSAP will continue to deepen its commitment to the field of brain health. Leveraging core technologies such as bioimpedance, pulsed magnetic therapy, and brain-computer interfaces, the company will continuously refine its closed-loop management model to drive the implementation of personalized solutions for Alzheimer's disease. At the same time, HSAP will actively promote the global expansion of its technologies, enabling China's original innovations to contribute to the global cause of brain health.